EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $407 | -100.0% | 345,000 | +93.3% | 0.64% | -62.7% |
Q3 2022 | $1,344,000 | -23.2% | 178,500 | -35.8% | 1.72% | -17.0% |
Q2 2022 | $1,751,000 | -1.0% | 277,909 | +30.5% | 2.07% | -25.7% |
Q1 2022 | $1,768,000 | +28.6% | 213,000 | -19.6% | 2.79% | +57.5% |
Q4 2021 | $1,375,000 | +5.5% | 265,000 | +35.8% | 1.77% | +0.9% |
Q3 2021 | $1,303,000 | -1.7% | 195,121 | +25.4% | 1.76% | -3.6% |
Q2 2021 | $1,325,000 | -0.5% | 155,573 | +3.4% | 1.82% | +21.0% |
Q1 2021 | $1,332,000 | -15.9% | 150,477 | +16.8% | 1.51% | -43.7% |
Q4 2020 | $1,584,000 | +56.5% | 128,848 | +3.6% | 2.68% | +21.7% |
Q3 2020 | $1,012,000 | -32.0% | 124,320 | -19.8% | 2.20% | -45.6% |
Q2 2020 | $1,488,000 | +54.8% | 155,000 | +9.7% | 4.04% | +20.3% |
Q1 2020 | $961,000 | -52.5% | 141,348 | +4.0% | 3.36% | -50.2% |
Q4 2019 | $2,024,000 | -9.0% | 135,848 | -37.4% | 6.74% | +5.1% |
Q3 2019 | $2,225,000 | -44.2% | 217,029 | -42.3% | 6.42% | +108.4% |
Q2 2019 | $3,986,000 | +100.6% | 376,035 | +164.6% | 3.08% | +205.2% |
Q1 2019 | $1,987,000 | +28.4% | 142,140 | -6.7% | 1.01% | +2.2% |
Q4 2018 | $1,548,000 | +239.5% | 152,406 | +301.1% | 0.99% | +376.8% |
Q3 2018 | $456,000 | -4.2% | 38,000 | -2.6% | 0.21% | +14.4% |
Q2 2018 | $476,000 | – | 39,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |